SCHEMBL3170981

SCHEMBL3170981

CCOC(=O)C1CCCN(C(=O)C(=O)Nc2cc(NCCNC(C)=O)nc(-c3ccccc3)n2)C1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.49
▸ SMN1; SMN2 Q16637 6/20 0.48
▸ HPGD P15428 4/20 0.48
▸ NPC1 O15118 3/20 0.48
▸ RAB9A P51151 3/20 0.48
▸ TSHR P16473 3/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ ALDH1A1 P00352 5/20 0.46
▸ GAA P10253 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ NPSR1 Q6W5P4 2/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ P2RY12 Q9H244 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3164656 0.90 MEN1 (0.46) SMN1; SMN2HPGDTSHRMEN1KMT2A
SCHEMBL3174310 0.89 ADORA2A (0.43) ALDH1A1KDM4EP2RY12
SCHEMBL3161848 0.88 HPGD (0.49) HPGDTSHRALDH1A1GAAMAPT
SCHEMBL3170604 0.86 ADORA2A (0.40) TSHRKMT2AALDH1A1MAPTCYP3A4
SCHEMBL3174594 0.85 ADORA2A (0.45) TSHRALDH1A1MAPTCYP3A4CYP2C9
SCHEMBL3166225 0.85 ADORA2A (0.45) TSHRALDH1A1MAPTCYP3A4CYP2C9
SCHEMBL3155863 0.85 NPC1 (0.40) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL3162937 0.84 ADORA2A (0.46) TSHRALDH1A1MAPTCYP3A4KDM4E
SCHEMBL3169774 0.81 ADORA2A (0.43) TSHRALDH1A1MAPTCYP3A4KDM4E
SCHEMBL3161815 0.80 ADORA2A (0.42) HTTTSHRKMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback